No Result

View All Result

No products in the cart.

Home All Specialties Chronic Disease

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

in Chronic Disease

RELATED REPORTS

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

RelatedReports

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

Pharma

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

August 20, 2025

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

2 Minute Medicine Rewind January 11, 2021

Lansoprazole not effective for the treatment of persistent throat symptoms

#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result